Global Companion Diagnostics Market Projections, SWOT Analysis, Trends and Forecast by 2022 - Market Research Report 2017

According to Stratistics MRC, the Global Companion Diagnostics Market is accounted for $2.62 billion in 2015 and is expected to reach $9.27 billion by 2022 growing at a CAGR of 19.78% during the forecast period. At present, increasing demand for personalized medicine is mostly contributing to the global companion diagnostics market growth. On the other hand, cost allied with developing drugs could hamper the market. Developing companion diagnostics for several central nervous system conditions and hereditary conditions provide ample of opportunities for players in the market.

Browse the report: http://www.orbisresearch.com/reports/index/companion-diagnostics-global-market-outlook-2015-2022

In terms of revenue, Breast cancer commanded the global companion diagnostics market. However, lung cancer is expected to lead the market in future growing at a significant CAGR owing to the discovery of biomarkers that are precise to lung cancer, and the discovery of myriad pertinent companion diagnostics. Molecular diagnostics is highest revenue generating segment and also expected to grow at a faster rate, mainly owing to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing.

North America represented the largest market for companion diagnostics, followed by the Europe. The Asia Pacific and Rest of the World regions are anticipated to witness substantial demand for companion diagnostics in the future. In these regions, enhancing healthcare infrastructure, rising disposable incomes, and unexploited potential for companion diagnostics are cited as the major reasons for the market growth.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184640

Some of the key players in the market include are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.

Technologies Covered:
Molecular diagnostics
In Situ Hybridization (ISH)
CISH
FISH
Polymerase Chain Reaction (PCR)
Next generation sequencing
Other Technologies
Immunohistochemistry

Applications Covered:
Colorectal Cancer
Gastric Cancer
Lung Cancer
Breast Cancer
Melanoma
Other Applications
Indications Covered:
Cardiovascular conditions
Inflammation
Virology
Oncology
Other Indications

End User’s Covered:
Pharmaceutical Companies
Reference Lab
Physicians
Hospitals
Academic Medical Centers

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

List Of Tables:

1 Global Companion Diagnostics Market Outlook, By Region
2 Global Companion Diagnostics Market Outlook, By Technology
3 Global Companion Diagnostics Market Outlook, By Molecular diagnostics
4 Global Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH)
5 Global Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR)
6 Global Companion Diagnostics Market Outlook, By Next generation sequencing
7 Global Companion Diagnostics Market Outlook, By Other Technologies
8 Global Companion Diagnostics Market Outlook, By Immunohistochemistry
9 Global Companion Diagnostics Market Outlook, By Application
10 Global Companion Diagnostics Market Outlook, By Colorectal Cancer
11 Global Companion Diagnostics Market Outlook, By Gastric Cancer
12 Global Companion Diagnostics Market Outlook, By Lung Cancer
13 Global Companion Diagnostics Market Outlook, By Breast Cancer
14 Global Companion Diagnostics Market Outlook, By Melanoma
15 Global Companion Diagnostics Market Outlook, By Other Applications
16 Global Companion Diagnostics Market Outlook, By Indication
17 Global Companion Diagnostics Market Outlook, By Cardiovascular conditions
18 Global Companion Diagnostics Market Outlook, By Inflammation
19 Global Companion Diagnostics Market Outlook, By Virology
20 Global Companion Diagnostics Market Outlook, By Oncology

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.